Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Danshensu
Cat. No.:
OB0125LY-097
Appearance:
Solid
Purity:
99.7%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
Danshensu is a terpene compound with good water solubility.
Synonym:
76822-21-4; Salvianic acid A; Dan shen suan A; (R)-3-(3,4-Dihydroxyphenyl)-2-hydroxypropanoic acid; (2R)-3-(3,4-Dihydroxyphenyl)-2-hydroxypropanoic acid; (2R)-3-(3,4-Dihydroxyphenyl)lactic acid; (2~{R})-3-[3,4-bis (oxidanyl)phenyl]-2-oxidanyl-propanoic acid; (R)-3-(3,4-dihydroxyphenyl)lactate
CAS No.:
76822-21-4
Compound CID:
11600642
Formula:
C9H10O5
Formula Weight:
198.17
Specification
Relative Density:
1.546 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Danshensu has antioxidant, anti-inflammatory, and antiplatelet aggregation properties that play a role in cardiovascular disease research.
Library Information
Targets:
Autophagy; Apoptosis; Nrf2
Receptors:
Apoptosis; Autophagy; Keap1-Nrf2
Pathways:
Autophagy; Apoptosis; Immunology/Inflammation
Plate Number:
AOCL-7
Plate Location:
a3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
10 mg/mL; 50.46 mM
ALogP:
0.679
HBA_Count:
1
HBD_Count:
3
Rotatable Bond:
3
